Anti-IL-4Rα monoclonal antibody (CM310) in patients with chronic rhinosinusitis with nasal polyps (CROWNS-2): Rationale and design of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study
Authors
Bing Yan (ORCID: https://orcid.org/0000-0002-7970-6764)
Chengshuo Wang (ORCID: https://orcid.org/0000-0003-0646-5135)
Luo Zhang (ORCID: https://orcid.org/0000-0002-0910-9884)
Ming Wang (ORCID: https://orcid.org/0000-0002-8560-3964)
Anti-IL-4Rα monoclonal antibody (CM310) in patients with chronic rhinosinusitis with nasal polyps (CROWNS-2): Rationale and design of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study
Bing Yan, Chengshuo Wang, Luo Zhang, Ming Wang et al.
Citations
10 citations
Journal
Asia Pacific Allergy
Topics
Sinusitis and nasal conditions
Field-Weighted Citation Impact (FWCI)
5.80
article
Anti-IL-4Rα monoclonal antibody (CM310) in patients with chronic rhinosinusitis with nasal polyps (CROWNS-2): Rationale and design of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study
Bing Yan, Chengshuo Wang, Luo Zhang, Ming Wang, Shen Shen, Di Wu
article en
10 citations
Abstract
No abstract available for this paper.
Publication Tag
Asia Pacific AllergyVol. 14(3)
Institutions
Beijing Tongren Hospital (CN), Capital Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN)